PRRT2 and chronic obstructive pulmonary disease: Several inhibitors for various kinases are under development as a treatment of COPD [30,31]; however, PKC inhibitors have been poorly studied for that purpose, although PKCs are important signaling mediators in chronic airway diseases, including COPD [32].